Schedule 13G ownership disclosure

Ironwood Pharmaceuticals Inc

Common Stock · CUSIP: 46333X108

Event date: 2024-12-31

Filing-level shares
19,538,555
Percent of class
12.2%
  • The Vanguard Group

    Shares: 19,538,555 · Class: 12.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-25-000291
Form type
SCHEDULE 13G/A
Filer
IRONWOOD PHARMACEUTICALS INC
CIK
CIK 1446847
Filed
Jan 31, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub